Global Atherosclerosis Drug Market Growth (Status and Outlook) 2025-2031

September 2025 | 81 pages | ID: GAA8A048E78BEN
LP Information

Abstracts

According to this study, the global Atherosclerosis Drug market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Atherosclerosis Drug Industry Forecast” looks at past sales and reviews total world Atherosclerosis Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Atherosclerosis Drug sales for 2025 through 2031. With Atherosclerosis Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atherosclerosis Drug industry.

This Insight Report provides a comprehensive analysis of the global Atherosclerosis Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Atherosclerosis Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Atherosclerosis Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atherosclerosis Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atherosclerosis Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Atherosclerosis Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Anti-platelet Medications
• Cholesterol Lowering Medications
• Fibric Acid and Omega-3 Fatty Acid Derivatives
• Other

Segmentation by Application:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Sanofi
• F. Hoffmann-La Roche
• Bayer
• Novartis
• Merck & Co
• Janssen Pharmaceuticals
• Mylan
• Amgen Inc
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atherosclerosis Drug Market Size (2020-2031)
  2.1.2 Atherosclerosis Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Atherosclerosis Drug by Country/Region (2020, 2024 & 2031)
2.2 Atherosclerosis Drug Segment by Type
  2.2.1 Anti-platelet Medications
  2.2.2 Cholesterol Lowering Medications
  2.2.3 Fibric Acid and Omega-3 Fatty Acid Derivatives
  2.2.4 Other
2.3 Atherosclerosis Drug Market Size by Type
  2.3.1 Atherosclerosis Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
2.4 Atherosclerosis Drug Segment by Application
  2.4.1 Retail Pharmacies
  2.4.2 Hospital Pharmacies
  2.4.3 Online Pharmacies
2.5 Atherosclerosis Drug Market Size by Application
  2.5.1 Atherosclerosis Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Atherosclerosis Drug Market Size Market Share by Application (2020-2025)

3 ATHEROSCLEROSIS DRUG MARKET SIZE BY PLAYER

3.1 Atherosclerosis Drug Market Size Market Share by Player
  3.1.1 Global Atherosclerosis Drug Revenue by Player (2020-2025)
  3.1.2 Global Atherosclerosis Drug Revenue Market Share by Player (2020-2025)
3.2 Global Atherosclerosis Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ATHEROSCLEROSIS DRUG BY REGION

4.1 Atherosclerosis Drug Market Size by Region (2020-2025)
4.2 Global Atherosclerosis Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atherosclerosis Drug Market Size Growth (2020-2025)
4.4 APAC Atherosclerosis Drug Market Size Growth (2020-2025)
4.5 Europe Atherosclerosis Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Atherosclerosis Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Atherosclerosis Drug Market Size by Country (2020-2025)
5.2 Americas Atherosclerosis Drug Market Size by Type (2020-2025)
5.3 Americas Atherosclerosis Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atherosclerosis Drug Market Size by Region (2020-2025)
6.2 APAC Atherosclerosis Drug Market Size by Type (2020-2025)
6.3 APAC Atherosclerosis Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Atherosclerosis Drug Market Size by Country (2020-2025)
7.2 Europe Atherosclerosis Drug Market Size by Type (2020-2025)
7.3 Europe Atherosclerosis Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atherosclerosis Drug by Region (2020-2025)
8.2 Middle East & Africa Atherosclerosis Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Atherosclerosis Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ATHEROSCLEROSIS DRUG MARKET FORECAST

10.1 Global Atherosclerosis Drug Forecast by Region (2026-2031)
  10.1.1 Global Atherosclerosis Drug Forecast by Region (2026-2031)
  10.1.2 Americas Atherosclerosis Drug Forecast
  10.1.3 APAC Atherosclerosis Drug Forecast
  10.1.4 Europe Atherosclerosis Drug Forecast
  10.1.5 Middle East & Africa Atherosclerosis Drug Forecast
10.2 Americas Atherosclerosis Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Atherosclerosis Drug Forecast
  10.2.2 Canada Market Atherosclerosis Drug Forecast
  10.2.3 Mexico Market Atherosclerosis Drug Forecast
  10.2.4 Brazil Market Atherosclerosis Drug Forecast
10.3 APAC Atherosclerosis Drug Forecast by Region (2026-2031)
  10.3.1 China Atherosclerosis Drug Market Forecast
  10.3.2 Japan Market Atherosclerosis Drug Forecast
  10.3.3 Korea Market Atherosclerosis Drug Forecast
  10.3.4 Southeast Asia Market Atherosclerosis Drug Forecast
  10.3.5 India Market Atherosclerosis Drug Forecast
  10.3.6 Australia Market Atherosclerosis Drug Forecast
10.4 Europe Atherosclerosis Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Atherosclerosis Drug Forecast
  10.4.2 France Market Atherosclerosis Drug Forecast
  10.4.3 UK Market Atherosclerosis Drug Forecast
  10.4.4 Italy Market Atherosclerosis Drug Forecast
  10.4.5 Russia Market Atherosclerosis Drug Forecast
10.5 Middle East & Africa Atherosclerosis Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Atherosclerosis Drug Forecast
  10.5.2 South Africa Market Atherosclerosis Drug Forecast
  10.5.3 Israel Market Atherosclerosis Drug Forecast
  10.5.4 Turkey Market Atherosclerosis Drug Forecast
10.6 Global Atherosclerosis Drug Forecast by Type (2026-2031)
10.7 Global Atherosclerosis Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Atherosclerosis Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline Atherosclerosis Drug Product Offered
  11.1.3 GlaxoSmithKline Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Atherosclerosis Drug Product Offered
  11.2.3 Sanofi Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 F. Hoffmann-La Roche
  11.3.1 F. Hoffmann-La Roche Company Information
  11.3.2 F. Hoffmann-La Roche Atherosclerosis Drug Product Offered
  11.3.3 F. Hoffmann-La Roche Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 F. Hoffmann-La Roche Main Business Overview
  11.3.5 F. Hoffmann-La Roche Latest Developments
11.4 Bayer
  11.4.1 Bayer Company Information
  11.4.2 Bayer Atherosclerosis Drug Product Offered
  11.4.3 Bayer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Main Business Overview
  11.4.5 Bayer Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Atherosclerosis Drug Product Offered
  11.5.3 Novartis Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Merck & Co
  11.6.1 Merck & Co Company Information
  11.6.2 Merck & Co Atherosclerosis Drug Product Offered
  11.6.3 Merck & Co Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck & Co Main Business Overview
  11.6.5 Merck & Co Latest Developments
11.7 Janssen Pharmaceuticals
  11.7.1 Janssen Pharmaceuticals Company Information
  11.7.2 Janssen Pharmaceuticals Atherosclerosis Drug Product Offered
  11.7.3 Janssen Pharmaceuticals Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Janssen Pharmaceuticals Main Business Overview
  11.7.5 Janssen Pharmaceuticals Latest Developments
11.8 Mylan
  11.8.1 Mylan Company Information
  11.8.2 Mylan Atherosclerosis Drug Product Offered
  11.8.3 Mylan Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Mylan Main Business Overview
  11.8.5 Mylan Latest Developments
11.9 Amgen Inc
  11.9.1 Amgen Inc Company Information
  11.9.2 Amgen Inc Atherosclerosis Drug Product Offered
  11.9.3 Amgen Inc Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Amgen Inc Main Business Overview
  11.9.5 Amgen Inc Latest Developments
11.10 Pfizer
  11.10.1 Pfizer Company Information
  11.10.2 Pfizer Atherosclerosis Drug Product Offered
  11.10.3 Pfizer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Pfizer Main Business Overview
  11.10.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Atherosclerosis Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Atherosclerosis Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-platelet Medications
Table 4. Major Players of Cholesterol Lowering Medications
Table 5. Major Players of Fibric Acid and Omega-3 Fatty Acid Derivatives
Table 6. Major Players of Other
Table 7. Atherosclerosis Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Atherosclerosis Drug Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
Table 10. Atherosclerosis Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Atherosclerosis Drug Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Atherosclerosis Drug Market Size Market Share by Application (2020-2025)
Table 13. Global Atherosclerosis Drug Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Atherosclerosis Drug Revenue Market Share by Player (2020-2025)
Table 15. Atherosclerosis Drug Key Players Head office and Products Offered
Table 16. Atherosclerosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Atherosclerosis Drug Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Atherosclerosis Drug Market Size Market Share by Region (2020-2025)
Table 21. Global Atherosclerosis Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Atherosclerosis Drug Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Atherosclerosis Drug Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Atherosclerosis Drug Market Size Market Share by Country (2020-2025)
Table 25. Americas Atherosclerosis Drug Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
Table 27. Americas Atherosclerosis Drug Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Atherosclerosis Drug Market Size Market Share by Application (2020-2025)
Table 29. APAC Atherosclerosis Drug Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Atherosclerosis Drug Market Size Market Share by Region (2020-2025)
Table 31. APAC Atherosclerosis Drug Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Atherosclerosis Drug Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Atherosclerosis Drug Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Atherosclerosis Drug Market Size Market Share by Country (2020-2025)
Table 35. Europe Atherosclerosis Drug Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Atherosclerosis Drug Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Atherosclerosis Drug Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Atherosclerosis Drug Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Atherosclerosis Drug Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Atherosclerosis Drug
Table 41. Key Market Challenges & Risks of Atherosclerosis Drug
Table 42. Key Industry Trends of Atherosclerosis Drug
Table 43. Global Atherosclerosis Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Atherosclerosis Drug Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Atherosclerosis Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Atherosclerosis Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. GlaxoSmithKline Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 48. GlaxoSmithKline Atherosclerosis Drug Product Offered
Table 49. GlaxoSmithKline Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. GlaxoSmithKline Main Business
Table 51. GlaxoSmithKline Latest Developments
Table 52. Sanofi Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 53. Sanofi Atherosclerosis Drug Product Offered
Table 54. Sanofi Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. F. Hoffmann-La Roche Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 58. F. Hoffmann-La Roche Atherosclerosis Drug Product Offered
Table 59. F. Hoffmann-La Roche Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. F. Hoffmann-La Roche Main Business
Table 61. F. Hoffmann-La Roche Latest Developments
Table 62. Bayer Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 63. Bayer Atherosclerosis Drug Product Offered
Table 64. Bayer Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Bayer Main Business
Table 66. Bayer Latest Developments
Table 67. Novartis Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 68. Novartis Atherosclerosis Drug Product Offered
Table 69. Novartis Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Novartis Main Business
Table 71. Novartis Latest Developments
Table 72. Merck & Co Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 73. Merck & Co Atherosclerosis Drug Product Offered
Table 74. Merck & Co Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Merck & Co Main Business
Table 76. Merck & Co Latest Developments
Table 77. Janssen Pharmaceuticals Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 78. Janssen Pharmaceuticals Atherosclerosis Drug Product Offered
Table 79. Janssen Pharmaceuticals Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Janssen Pharmaceuticals Main Business
Table 81. Janssen Pharmaceuticals Latest Developments
Table 82. Mylan Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 83. Mylan Atherosclerosis Drug Product Offered
Table 84. Mylan Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Mylan Main Business
Table 86. Mylan Latest Developments
Table 87. Amgen Inc Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 88. Amgen Inc Atherosclerosis Drug Product Offered
Table 89. Amgen Inc Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Amgen Inc Main Business
Table 91. Amgen Inc Latest Developments
Table 92. Pfizer Details, Company Type, Atherosclerosis Drug Area Served and Its Competitors
Table 93. Pfizer Atherosclerosis Drug Product Offered
Table 94. Pfizer Atherosclerosis Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Atherosclerosis Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Atherosclerosis Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Atherosclerosis Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Atherosclerosis Drug Sales Market Share by Country/Region (2024)
Figure 8. Atherosclerosis Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Atherosclerosis Drug Market Size Market Share by Type in 2024
Figure 10. Atherosclerosis Drug in Retail Pharmacies
Figure 11. Global Atherosclerosis Drug Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 12. Atherosclerosis Drug in Hospital Pharmacies
Figure 13. Global Atherosclerosis Drug Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 14. Atherosclerosis Drug in Online Pharmacies
Figure 15. Global Atherosclerosis Drug Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Atherosclerosis Drug Market Size Market Share by Application in 2024
Figure 17. Global Atherosclerosis Drug Revenue Market Share by Player in 2024
Figure 18. Global Atherosclerosis Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Atherosclerosis Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Atherosclerosis Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Atherosclerosis Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Atherosclerosis Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Atherosclerosis Drug Value Market Share by Country in 2024
Figure 24. United States Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Atherosclerosis Drug Market Size Market Share by Region in 2024
Figure 29. APAC Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Atherosclerosis Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Atherosclerosis Drug Market Size Market Share by Country in 2024
Figure 38. Europe Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Atherosclerosis Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Atherosclerosis Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Atherosclerosis Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Atherosclerosis Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Atherosclerosis Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 61. China Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 65. India Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 68. France Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Atherosclerosis Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Atherosclerosis Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Atherosclerosis Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Atherosclerosis Drug Market Size 2026-2031 ($ millions)